Skip to main content
Clinical Trials/NCT01282996
NCT01282996
Completed
Phase 4

Intraoperative Lung Protective Ventilation in Abdominal Surgery: A Randomized Controlled Study

University Hospital, Clermont-Ferrand1 site in 1 country400 target enrollmentJanuary 2011

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Protective Lung Ventilation Using:
Sponsor
University Hospital, Clermont-Ferrand
Enrollment
400
Locations
1
Primary Endpoint
Composite endpoint defined as incidence of major postoperative pulmonary (defined as pneumonia, need for noninvasive ventilation or need for invasive ventilation) and extrapulmonary (SIRS, sepsis and septic shock) complications
Status
Completed
Last Updated
13 years ago

Overview

Brief Summary

The purpose of this study is to compare the influence of a lung protective ventilation with conventional ventilation on postoperative complications following major abdominal surgery.

Detailed Description

Postoperative complications are associated with a significant and quantifiable rate of both morbidity and mortality, increased length of hospital stay and cost of care. Intra-abdominal surgery, especially upper abdominal surgery, is an important risk factor of both pulmonary and extra-pulmonary complications. Up to 15-20% of patients will develop postoperative respiratory failure which may require respiratory support. Recent data from both experimental and clinical studies suggested that, compared with conventional ventilation using high tidal volume (TV) without positive end-expiratory pressure (PEEP), intraoperative lung protective ventilation using low tidal volume, PEEP and recruitment maneuvers (RM) could reduce postoperative complications. Conventional ventilation promotes sustained cytokine production and could therefore contribute to development of lung injury with in patients with normal lungs. Conversely, lung protective ventilation was found to reduce pulmonary and systemic inflammation. The primary objective is to compare a lung protective ventilation with conventional ventilation (high tidal volumes without PEEP) during abdominal surgery: 1- Conventional ventilation with TV of 10-12 mL/kg predicted body weight (PBW) without PEEP; 2- Protective lung ventilation with TV of 6-8 mL/kg PBW, PEEP of 6-8 cmH2O and RM. Our hypothesis is that lung protective ventilation could reduce postoperative pulmonary and extra-pulmonary complications compared with conventional ventilation.

Registry
clinicaltrials.gov
Start Date
January 2011
End Date
August 2012
Last Updated
13 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
University Hospital, Clermont-Ferrand
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Planned intrabdominal surgery
  • Expected duration ≥ 2 hours
  • Age ≥ 40 yr (and \<90 yr)
  • Risk of postoperative pulmonary complications (Arozullah score ≥2)

Exclusion Criteria

  • Noninvasive ventilation in the last 30 days
  • Recent history of pneumonia, ALI/ARDS (in the last 30 days)
  • History of pulmonary resection
  • History of neuromuscular disease
  • Patient refusal

Outcomes

Primary Outcomes

Composite endpoint defined as incidence of major postoperative pulmonary (defined as pneumonia, need for noninvasive ventilation or need for invasive ventilation) and extrapulmonary (SIRS, sepsis and septic shock) complications

Time Frame: during the first seven days after surgery

Secondary Outcomes

  • Other postoperative complications (reintervention, wound abscess, ...)(at day 15 after surgery)
  • Major complications: postoperative hypoxemia, postoperative pneumonia, acute lung injury (ALI), acute respiratory distress syndrome (ARDS), pulmonary embolism(at day 15 after surgery)
  • Minor complications : atelectasis, anastomotic leakage, intrabdominal abscess(at day 15 after surgery)
  • Systemic level of marker of inflammation (C Reactive protein)(at day 15 after surgery)
  • Postoperative complications at day 30 after surgery(at day 30 after surgery)
  • Need for ICU admission(at day 30 after surgery)
  • ICU length of stay(at day 30 after surgery)
  • Hospital length of stay(at day 30 after surgery)
  • Mortality(at day 30 after surgery)
  • Plasma levels of the soluble form of the receptor for advanced glycation end-products (sRAGE), a marker of alveolar type I cell injury(before surgery, during the immediate postoperative period and on day 1, day 3 and day 7 after surgery)

Study Sites (1)

Loading locations...

Similar Trials